Performance Comparison of the


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2020
Historique:
received: 20 01 2020
revised: 04 03 2020
accepted: 24 03 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 11 2 2021
Statut: epublish

Résumé

Over 240 million people are chronically infected with hepatitis B virus (HBV), the leading cause of liver cancer worldwide. The quantification of the HBV DNA level is critical for monitoring the efficacy of antiviral treatment of chronic HBV patients. In our study, we compared the performance of the Detection rates and viral loads quantified by the The

Sections du résumé

BACKGROUND BACKGROUND
Over 240 million people are chronically infected with hepatitis B virus (HBV), the leading cause of liver cancer worldwide. The quantification of the HBV DNA level is critical for monitoring the efficacy of antiviral treatment of chronic HBV patients.
METHODS METHODS
In our study, we compared the performance of the
RESULTS RESULTS
Detection rates and viral loads quantified by the
CONCLUSION CONCLUSIONS
The

Identifiants

pubmed: 32351992
doi: 10.1155/2020/4159189
pmc: PMC7178467
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4159189

Informations de copyright

Copyright © 2020 Salma Madihi et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

Ann Lab Med. 2017 May;37(3):248-253
pubmed: 28224771
Infect Genet Evol. 2008 May;8(3):306-12
pubmed: 18372221
Infect Genet Evol. 2012 Aug;12(6):1157-62
pubmed: 22579480
J Clin Virol. 2014 Jul;60(3):206-14
pubmed: 24809730
J Hepatol. 2003;39 Suppl 1:S31-5
pubmed: 14708675
Lancet. 2016 Sep 10;388(10049):1081-1088
pubmed: 27394647
J Hepatol. 2017 Aug;67(2):370-398
pubmed: 28427875
J Clin Virol. 2009 Jul;45(3):232-6
pubmed: 19535286
Virol J. 2017 May 12;14(1):94
pubmed: 28494793
J Clin Gastroenterol. 2015 Apr;49(4):323-8
pubmed: 25014234
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Ann Transl Med. 2016 Sep;4(18):338
pubmed: 27761442
J Clin Virol. 2007 Feb;38(2):184-5
pubmed: 17067853
BMC Public Health. 2013 Jan 18;13:50
pubmed: 23331910
J Clin Virol. 2018 Apr;101:47-51
pubmed: 29414188

Auteurs

Salma Madihi (S)

Molecular Biology Laboratory, Pasteur Institute of Morocco, 1, Place Louis Pasteur, Casablanca 20360, Morocco.
Team of Experimental Oncology and Natural Substances, Cellular and Molecular Immunopharmacology, Sultan Moulay Slimane University, Faculty of Sciences and Technologies, Beni Mellal, Morocco.

Hashim Syed (H)

Molecular Biology Laboratory, Pasteur Institute of Morocco, 1, Place Louis Pasteur, Casablanca 20360, Morocco.

Fatiha Lazar (F)

Molecular Biology Laboratory, Pasteur Institute of Morocco, 1, Place Louis Pasteur, Casablanca 20360, Morocco.

Abdelmajid Zyad (A)

Team of Experimental Oncology and Natural Substances, Cellular and Molecular Immunopharmacology, Sultan Moulay Slimane University, Faculty of Sciences and Technologies, Beni Mellal, Morocco.

Abdelouaheb Benani (A)

Molecular Biology Laboratory, Pasteur Institute of Morocco, 1, Place Louis Pasteur, Casablanca 20360, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH